Generics in South Korea

November 2019 | 43 pages | ID: GFBC37A9119EN
MarketLine

Abstracts

Generics in South Korea

SUMMARY

Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
• The South Korean generics market had total revenues of $5.1bn in 2018, representing a compound annual growth rate (CAGR) of 7.8% between 2014 and 2018.
• Market consumption volume increased with a CAGR of 3.1% between 2014 and 2018, to reach 73.2% of total pharma volume.
• Generics are becoming more and more popular in South Korea as the government realizes the cost saving potential.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Korea
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
• Leading company profiles reveal details of key generics market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts by both value and volume

REASONS TO BUY

• What was the size of the South Korea generics market by value in 2018?
• What will be the size of the South Korea generics market in 2023?
• What factors are affecting the strength of competition in the South Korea generics market?
• How has the market performed over the last five years?
• How large is South Korea’s generics market in relation to its regional counterparts?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value
3.2. Market volume

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast
5.2. Market volume forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. Which players have been most successful in the recent past (1-3 years)?

8 COMPANY PROFILES

8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Mylan N.V.
8.4. Yuhan Corp

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: South Korea generics market value: $ million, 2014-18
Table 2: South Korea generics market volume: % of total pharma, 2014-18
Table 3: South Korea generics market geography segmentation: $ million, 2018
Table 4: South Korea generics market value forecast: $ million, 2018-23
Table 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Mylan N.V.: key facts
Table 14: Mylan N.V.: Annual Financial Ratios
Table 15: Mylan N.V.: Key Employees
Table 16: Yuhan Corp: key facts
Table 17: Yuhan Corp: Annual Financial Ratios
Table 18: Yuhan Corp: Key Employees
Table 19: South Korea size of population (million), 2014-18
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2014-18
Table 21: South Korea gdp (current prices, $ billion), 2014-18
Table 22: South Korea inflation, 2014-18
Table 23: South Korea consumer price index (absolute), 2014-18
Table 24: South Korea exchange rate, 2014-18

List Of Figures

LIST OF FIGURES

Figure 1: South Korea generics market value: $ million, 2014-18
Figure 2: South Korea generics market volume: % of total pharma, 2014-18
Figure 3: South Korea generics market geography segmentation: % share, by value, 2018
Figure 4: South Korea generics market value forecast: $ million, 2018-23
Figure 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Figure 6: Forces driving competition in the generics market in South Korea, 2018
Figure 7: Drivers of buyer power in the generics market in South Korea, 2018
Figure 8: Drivers of supplier power in the generics market in South Korea, 2018
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2018
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2018
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2018

COMPANIES MENTIONED

Pfizer Inc.
Teva Pharmaceutical Industries Limited
Mylan N.V.
Yuhan Corp